By Venture Planning Group "...... ysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future market trends; forecasts......" | 22-Jun-2021 | $38500 |
By Venture Planning Group "...... over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future market trends; forecasts specim......" | 22-Jun-2021 | $14500 |
By Venture Planning Group "...... over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future market trends; forecasts specim......" | 22-Jun-2021 | $24500 |
By Venture Planning Group "...... try and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some s......" | 22-Jun-2021 | $14500 |
By Venture Planning Group "...... ry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some se......" | 22-Jun-2021 | $9500 |
By Venture Planning Group "...... over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future market trends; forecasts specim......" | 22-Jun-2021 | $9500 |
By Venture Planning Group "...... xplores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of lead......" | 22-Jun-2021 | $24500 |
By Venture Planning Group "...... eport explores future trends in major European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; pro......" | 22-Jun-2021 | $14500 |
By Venture Planning Group "...... ends in the French market; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketin......" | 22-Jun-2021 | $4500 |
By Venture Planning Group "...... ends in the German market; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketin......" | 22-Jun-2021 | $4500 |
|